Vistin Pharma ASA: Minutes from the annual general meeting 2024
May 23, 2024 08:50 ET
|
Vistin Pharma ASA
Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in...
Disclosure of voting rights at AGM in Vistin Pharma ASA
May 23, 2024 06:56 ET
|
Vistin Pharma ASA
Oslo, Norway, 23 May 2024 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open...
Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024
April 30, 2024 02:58 ET
|
Vistin Pharma ASA
Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 23 May 2024 at 13:00 CEST. A physical...
Vistin Pharma ASA: Annual Report 2023
April 24, 2024 17:10 ET
|
Vistin Pharma ASA
Oslo, Norway, 24 April 2024 Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full...
Vistin Pharma ASA: First quarter 2024 financial results
April 24, 2024 01:44 ET
|
Vistin Pharma ASA
Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to...
Vistin Pharma ASA: Invitation to Q1 2024 conference call
April 16, 2024 07:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will host a conference call for all shareholders and interested...
Vistin Pharma ASA: Mandatory notification of trade
March 22, 2024 16:59 ET
|
Vistin Pharma ASA
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and...
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
March 04, 2024 02:15 ET
|
Vistin Pharma ASA
Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international...
Vistin Pharma ASA: Key information relating to the proposed cash dividend
February 16, 2024 04:30 ET
|
Vistin Pharma ASA
The Board of Directors of Vistin Pharma ASA plans to propose to distribute a cash dividend of total NOK 1.00 per share, to be paid partly in June and November, for the accounting year of 2023. The...
Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results
February 16, 2024 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 16th of February 2024 Vistin Pharma ASA (Vistin Pharma, OSE: VISTN) today announces the financial results for the fourth quarter of 2023. Vistin delivers another strong quarter with...